Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine
- 15 January 1994
- Vol. 73 (2) , 432-436
- https://doi.org/10.1002/1097-0142(19940115)73:2<432::aid-cncr2820730231>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- LONG‐TERM TREATMENT OF METASTATIC MEDULLARY THYROID CARCINOMA WITH THE SOMATOSTATIN ANALOGUE OCTREOTIDEClinical Endocrinology, 1990
- Medullary Thyroid Carcinoma: Prognosis of FamilialVersusSporadic Disease and the Role of Radiotherapy*Journal of Clinical Endocrinology & Metabolism, 1988
- Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and DacarbazineAnnals of Internal Medicine, 1988
- Chemotherapy for thyroid cancerRadiotherapy and Oncology, 1987
- Medullary Carcinoma of the ThyroidMedicine, 1984
- Medullary thyroid carcinoma: Prognostic factors and treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Management of medullary carcinoma of the thyroidThe American Journal of Surgery, 1982
- The Prognostic and Biological Significance of Cellular Heterogeneity in Medullary Thyroid Carcinoma: A Study of Calcitonin, L-Dopa Decarboxylase, and Histaminase*Journal of Clinical Endocrinology & Metabolism, 1982
- Failure of Medullary Carcinoma of the Thyroid to Respond to Doxorubicin TherapyHormone Research, 1978